Medicus Pharma Ltd. is a biotech life sciences company, which focuses on accelerating the clinical development programs of novel and disruptive therapeutic assets. It develops a product, SkinJectTM, with an indication for basal cell carcinoma. The company was founded on April 30, 2008 and is headquartered in Toronto, Canada.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
12
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Medicus Pharma Ltd market cap is $13.29M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Medicus Pharma Ltd 52 week high is $8.94 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Medicus Pharma Ltd 52 week low is $0.37 as of November 22, 2026.
Medicus Pharma Ltd stock price today is $0.4941.
Medicus Pharma Ltd stock price yesterday was $0.52.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Medicus Pharma Ltd's P/E ratio is -0.31.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Medicus Pharma Ltd P/B ratio is -16.672.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Medicus Pharma Ltd 50-day moving average is $1.27.